Related Experiment Video
Updated: Feb 17, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Mitral valve repair versus replacement in elderly patients: a systematic review and meta-analysis
Xiaoke Shang1, Rong Lu2, Mei Liu2
1Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Background:
Although mitral valve repair (MVP) is generally accepted as the standard treatment for mitral valve disease, in older patients, there is increasing debate about whether MVP is superior to mitral valve replacement (MVR). We, therefore, performed a meta-analysis to compare MVP vs. MVR in the elderly population.
Methods:
We systematically searched PubMed, the Cochrane Library, and Scopus up to February 2017 and scrutinized the references of relevant literatures. Only studies of MVP vs. MVR in the elderly patients (aged 70 years or older) that were published after 2000 were included.
Results:
The retrieval process yielded seven observational clinical studies with 1,809 patients. Compared with MVR, MVP was associated with a significantly reduced 30-day mortality [risk ratio (RR): 0.40, 95% confidence interval (CI): 0.25-0.64], with shorter duration of postoperative hospital stay (days) (weighted mean difference: -1.47, 95% CI: -2.47--0.48) and less postoperative complications (RR: 0.69, 95% CI: 0.56-0.86). In addition, our study also demonstrated improved 1-year (RR: 1.16, 95% CI: 1.08-1.24) and 5-year (RR: 1.26, 95% CI: 1.13-1.41) survival rates following MVP. There was no difference in reoperations between these two surgery approaches.
Conclusions:
The present meta-analysis indicates that elderly patients who receive MVP have better early and late outcomes than those undergoing MVR. MVP may be the preferred strategy for mitral valve surgery in the elderly population.
Insights
Mitral valve repair (MVP) offers better early and late outcomes for elderly patients compared to mitral valve replacement (MVR). This meta-analysis suggests MVP is the preferred surgical strategy for this demographic.
Area of Science:
- Cardiovascular Surgery
- Geriatric Medicine
- Clinical Outcomes Research
Background:
- Mitral valve repair (MVP) is standard for mitral valve disease.
- Debate exists on MVP vs. mitral valve replacement (MVR) in older patients.
- Elderly patients (≥70 years) require comparative outcome data.
Purpose of the Study:
- To compare mitral valve repair (MVP) versus mitral valve replacement (MVR) in elderly patients.
- To evaluate early and late outcomes of MVP compared to MVR.
- To inform surgical strategy for mitral valve disease in the geriatric population.
Main Methods:
- Systematic literature search of PubMed, Cochrane Library, and Scopus up to February 2017.
- Inclusion of observational studies comparing MVP vs. MVR in patients aged 70 years or older, published after 2000.
- Meta-analysis of seven studies involving 1,809 patients.
Main Results:
- Mitral valve repair (MVP) was associated with significantly reduced 30-day mortality (RR: 0.40) and fewer postoperative complications (RR: 0.69) compared to MVR.
- MVP resulted in shorter postoperative hospital stays (WMD: -1.47 days).
- Improved 1-year (RR: 1.16) and 5-year (RR: 1.26) survival rates were observed with MVP; no difference in reoperations.
Conclusions:
- Mitral valve repair (MVP) demonstrates superior early and late outcomes in elderly patients compared to mitral valve replacement (MVR).
- MVP may be the preferred surgical approach for mitral valve disease in the elderly.
- Evidence supports MVP as a beneficial strategy for geriatric patients undergoing mitral valve surgery.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse I: Introduction
Mitral Stenosis I: Introduction
Mitral Valve Prolapse III: Nursing Management

